| 产品名称 | Glibenclamide potassium salt - Glyburide potassium salt |
| 产品货号 | Axon 2064 CAS [23047-14-5] MF C23H26ClK2N3O5SMW 570.18 Purity: 99% Soluble in water and DMSO Description Antidiabetic; KATP channel blocker; the drug inhibits the sulfonylurea receptor 1 (SUR1), the regulatory subunit of the ATP-sensitive potassium channels (KATP) in pancreatic β cells References Certificates Categories Extra info F Tomai et al. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 1994, 90(2), 700-705. A Marble. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents? Drugs 1971, 1(2), 109–115. Certificate of Analysis Material Safety Data Sheet Cardiovascular Cell Signaling & Oncology CNS Diabetes & Metabolism KCNJ11 Pfizer Licensed Products Kir6.2-SUR1 KATP channel blocker; inhibits SUR1 Chemical name 5-chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide potassium Source information Pfizer compound; Sold for research purposes under agreement from Pfizer Inc. Parent CAS No. [10238-21-8] Order Size Unit Price Stock 25 mg €50.00 In Stock |
| 产品价格 | 现货询价，电话：010-67529703 |
| 产品规格 | |
| 产品品牌 | axonmedchem |
| 产品概述 | |
| 产品详情 |
Glibenclamide potassium salt - Glyburide potassium saltAxon 2064 CAS [23047-14-5] MF C23H26ClK2N3O5S
Description
Antidiabetic; KATP channel blocker; the drug inhibits the sulfonylurea receptor 1 (SUR1), the regulatory subunit of the ATP-sensitive potassium channels (KATP) in pancreatic β cells
KATP channel blocker; inhibits SUR1
Chemical name5-chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide potassium Source informationPfizer compound; Sold for research purposes under agreement from Pfizer Inc.Parent CAS No.[10238-21-8] |
| 产品资料 |
